Merck (MRK) is reportedly planning to double the production of molnupiravir, an antiviral COVID pill, next year. The Financial Times reported the drugmaker has secured deals to provide COVID ...

with Merck's being 40 pills and Pfizer's being 30 pills. "As new variants of the virus continue to emerge, it is crucial to expand the country's arsenal of COVID-19 therapies using emergency use ...

Efforts to find an easy, early COVID-19 treatment ... who got the drug were hospitalized in the same time period. None died, officials with the pharmaceutical company Merck announced October ...

Portions of northern Delaware, northeast Maryland, central, northern, northwest, and southern New ... and Drug Administration, Merck could be the first to put out a pill to treat COVID-19.

By Manas Mishra and Michael Erman (Reuters) -Merck & Co said on Friday updated data from its study of its experimental COVID ... Pills like molnupiravir and Paxlovid could be promising new weapons ...

which has been keenly anticipated as the first drug therapy for mild to moderate COVID-19 that can be delivered outside the hospital. Merck, which is known as MSD outside the US and Canada ...

Merck has a handful of new deals under its belt and key drug ... will end at the beginning of August. Sales of Merck's Covid ...

While Merck's oral drug Molnupiravir has already been cleared by the United Kingdom to treat COVID-19, a Paraguayan laboratory has filed for its emergency registration in the South American ...

(JTA) — Israel’s government reached an agreement to buy tens of thousands of doses of Pfizer’s experimental new ... and Merck’s pill, called Molnupiravir, both work to stop the COVID ...